BJDX (Bluejay Diagnostics) Insider Ownership: 25.78 % (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJDX Bluejay Diagnostics Inc BJDX
22 GF Score
Price $0.92
! 1 Warning Sign
View Full Analysis

What is Bluejay Diagnostics Insider Ownership?

Bluejay Diagnostics BJDX -3.02% 22 Insider Ownership is 25.78 % as of Aug. 22, 2026. GuruFocus rates BJDX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bluejay Diagnostics's insider ownership is 25.78%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bluejay Diagnostics's Institutional Ownership is 5.69%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bluejay Diagnostics's Float Percentage Of Total Shares Outstanding is 94.36%.

Bluejay Diagnostics Insider Ownership Historical Data

* Premium members only.

The historical data trend for Bluejay Diagnostics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bluejay Diagnostics Insider Ownership Chart

Bluejay Diagnostics Historical Data

The historical data trend for Bluejay Diagnostics can be seen below:

2023-05-31 2023-06-30 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 19.78 19.78 56.78 56.78 53.87 20.35 20.35 25.78 25.78 25.78
BJDX
22GF Score
Bluejay Diagnostics Inc BJDX
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bluejay Diagnostics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 25.78 % mean?
Bluejay Diagnostics (BJDX) has a Insider Ownership of 25.78 % as of Aug. 22, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bluejay Diagnostics and its competitors.
Is Bluejay Diagnostics' Insider Ownership too high?
Bluejay Diagnostics' current Insider Ownership is 25.78 %. Overall, Bluejay Diagnostics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Bluejay Diagnostics' Insider Ownership compare to VTAK and PFSA?
Bluejay Diagnostics' Insider Ownership of 25.78 % can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Devices & Instruments company?
A good Insider Ownership depends on the Medical Devices & Instruments industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bluejay Diagnostics and its competitors. Bluejay Diagnostics's current Insider Ownership is 25.78 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bluejay Diagnostics stock overvalued right now?
Bluejay Diagnostics (BJDX) has a current Insider Ownership of 25.78 %. The current Insider Ownership is 25.78 %. Bluejay Diagnostics' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Bluejay Diagnostics (BJDX), the current Insider Ownership is 25.78 % as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bluejay Diagnostics Business Description

Address 360 Massachusetts Avenue, Suite 203, Acton, MA, USA, 01720
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
22GF Score

Get the complete analysis for BJDX

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.92
Price